Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares - Asset Resilience Ratio
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) has an Asset Resilience Ratio of 0.00% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Hong Kong Pharma Digital Technology Hold (HKPD) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2024–2026)
This chart shows how Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Hong Kong Pharma Digital Technology Hold.
Liquid Assets Composition Over Time
This chart breaks down Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read HKPD liabilities breakdown for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares Industry Peers by Asset Resilience Ratio
Compare Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
China National Accord Medicines Corp Ltd
SHE:000028 |
Medical Distribution | 0.96% |
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3 |
Medical Distribution | 4.48% |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607 |
Medical Distribution | 4.21% |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332 |
Medical Distribution | 0.00% |
Annual Asset Resilience Ratio for Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (2024–2026)
The table below shows the annual Asset Resilience Ratio data for Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2026-03-31 | 0.00% | $0.00 | $12.84 Million | -- |
| 2025-03-31 | 23.96% | $2.26 Million | $9.42 Million | -- |
| 2024-03-31 | 0.00% | $0.00 | $8.67 Million | -- |
About Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers customs clearance, drugs enlisting, warehouse, and other logistics services. In addition, it provides valu… Read more